PARP Inhibitor Resistance: A Tug-of-War in BRCA-Mutated Cells
Author:
Funder
Dutch Cancer Foundation (KWF)
Oncode
Netherlands Organisation for Scientific Research
European Research Council
Publisher
Elsevier BV
Subject
Cell Biology
Reference130 articles.
1. Hallmarks of cancer: the next generation;Hanahan;Cell,2011
2. Preserving replication fork integrity and competence via the homologous recombination pathway;Ait Saada;DNA Repair (Amst),2018
3. Linkage of early-onset familial breast cancer to chromosome 17q21;Hall;Science,1990
4. Mutational landscape and significance across 12 major cancer types;Kandoth;Nature,2013
5. Somatic mutation in cancer and normal cells;Martincorena;Science,2015
Cited by 290 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Asymmetric nucleosome PARylation at DNA breaks mediates directional nucleosome sliding by ALC1;Nature Communications;2024-02-02
2. Reclassifying BRCA1 c.4358-2A > G and BRCA2 c.475 + 5G > C variants from “Uncertain Significance” to “Pathogenic” based on minigene assays and clinical evidence;Journal of Cancer Research and Clinical Oncology;2024-02-01
3. PARP1-stabilised FOXQ1 promotes ovarian cancer progression by activating the LAMB3/WNT/β-catenin signalling pathway;Oncogene;2024-01-31
4. A novel targeted NGS panel identifies numerous homologous recombination deficiency (HRD)-associated gene mutations in addition to known BRCA mutations;Diagnostic Pathology;2024-01-06
5. PARP Inhibitors in Breast Cancer: a Short Communication;Current Oncology Reports;2024-01-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3